← Back
Data updated: Mar 10, 2026
PYROS PHARMS
Neurology
PYROS PHARMS is a pharmaceutical company focused on Neurology. Key products include VIGAFYDE.
2022
Since
2
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
Recent Activity
VIGAFYDE 2025-09-03
Efficacy
VIGAFYDE 2025-09-03
Labeling
VIGPODER 2024-09-12
REMS
VIGAFYDE 2024-09-12
REMS
VIGAFYDE 2024-06-17
Type 3 - New Dosage Form
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...